SCHEMBL4414065

SCHEMBL4414065

COc1cc2c(c(OC)c1-c1ccccc1)C(c1cccc(C(N)=O)c1)=NCC(=O)N2CC1CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.56
PDE4D Q08499 1/20 0.39
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
FYN P06241 1/20 0.37
PTGDR2 Q9Y5Y4 6/20 0.37
OPRK1 P41145 2/20 0.36
KCNH2 Q12809 1/20 0.35
ATR Q13535 1/20 0.35
DAGLA Q9Y4D2 1/20 0.34
USP2 O75604 1/20 0.34
POLB P06746 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
HTT P42858 1/20 0.34
ERN1 O75460 1/20 0.34
PIK3CG P48736 1/20 0.34
FAAH O00519 1/20 0.34
DRD2 P14416 1/20 0.34
DRD3 P35462 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4423211 0.95 PDE2A (0.54) PDE2APDE4DTP53MAPTFYN
SCHEMBL4424399 0.90 PDE2A (0.60) PDE2APDE4DTP53MAPTFYN
SCHEMBL4412620 0.88 PDE2A (0.60) PDE2APDE4DTP53MAPTFYN
SCHEMBL4411561 0.88 PDE2A (0.58) PDE2ATP53MAPTFYNPTGDR2
SCHEMBL4412658 0.86 PDE2A (0.72) PDE2APDE4DFYNOPRK1KCNH2
SCHEMBL4602359 0.86 PDE2A (0.58) PDE2APDE4DTP53MAPTFYN
SCHEMBL4414019 0.85 PDE2A (0.57) PDE2APDE4DTP53MAPTPTGDR2
SCHEMBL4410766 0.84 GABRA1 (0.42) PDE2APDE4DTP53MAPTPTGDR2
SCHEMBL4423000 0.82 PTGDR2 (0.55) PDE2ATP53MAPTPTGDR2HTT
SCHEMBL4415654 0.80 PTGDR2 (0.42) TP53PTGDR2TSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1749824-A1 Benzodiazepine derivatives, their preparation and the therapeutic use thereof NEURO3D (FR) 2007-02-07 EP claimed
US-7599133-B2 Optical part for camera and method of fabricating the same SANYO ELECTRIC CO., LTD. (JP) 2009-10-06 US disclosed
US-20090215752-A1 Compounds, preparation and therapeutic use thereof BAY CITY CAPITAL LLC 2009-08-27 US disclosed
US-20080204898-A1 OPTICAL PART FOR CAMERA AND METHOD OF FABRICATING THE SAME SANYO ELECTRIC CO., LTD. (JP) 2008-08-28 US disclosed
EP-1910315-A2 BENZODIAZEPINE DERIVATIVES, THEIR PREPARATION AND THE THERAPEUTIC USE THEREOF NEURO3D (FR) 2008-04-16 EP disclosed
WO-2007026254-A2 BENZODIAZEPINE DERIVATIVES , THEIR PREPARATION AND THE THERAPEUTIC USE THEREOF NEURO3D (FR) 2007-03-08 WO disclosed
EP-1749824-A1 Benzodiazepine derivatives, their preparation and the therapeutic use thereof NEURO3D (FR) 2007-02-07 EP disclosed
US-6897250-B1 Automobile interior or exterior trim material ASAHI DENKA KOGYO K. K. (JP) 2005-05-24 US disclosed
EP-0953596-B1 Automobile interior or exterior trim material ASAHI DENKA KOGYO KK (JP) 2003-10-29 EP disclosed
EP-0953596-A2 Automobile interior or exterior trim material ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 1999-11-03 EP disclosed
EP-0672619-B1 Lithium aluminium complex hydroxide salt, blending agent for resin and resin composition MIZUSAWA INDUSTRIAL CHEM (JP) 1999-06-02 EP disclosed
EP-0672619-A1 Lithium aluminium complex hydroxide salt, blending agent for resin and resin composition MIZUSAWA INDUSTRIAL CHEMICALS, LTD. (JP) 1995-09-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215752-A1 Compounds, preparation and therapeutic use thereof PDE12, PDE4B, PDE2A PDE2A 3/4885PDE4D 13/4885TP53 4884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.